Bionano Genomics, Inc. (0A4K.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 07:14PM GMT. Market open.
| Previous close | 2.0080 |
| Open | 2.0450 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 2.1900 - 2.2000 |
| 52-week range | 2.1900 - 2.2000 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 1.87 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Do Options Traders Know Something About Bionano (BNGO) Stock We Don't?
Investors need to pay close attention to Bionano (BNGO) stock based on the movements in the options market lately.
- Motley Fool
3 Incredibly Cheap Growth Stocks That Could Make You a Millionaire
Bionano Genomics, BioCryst Pharmaceuticals, and NRx Pharmaceuticals all have the potential to make their early shareholders rich.
- Motley Fool
Bionano Genomics, Inc (BNGO) Q3 2021 Earnings Call Transcript
Leading the call today is Dr. Erik Holmlin, CEO of Bionano. Such forward-looking statements are based upon current expectations, and there can be no assurances that the results contemplated in these statements will be realized.
© 2022 Yahoo. All rights reserved.
